PriMera Scientific Medicine and Public Health (ISSN: 2833-5627)

Review Article

Volume 8 Issue 2

Nutritional Strategies in the Management of Diabetes Mellitus: A Review

Deepa Rajendiran, Saravanan Radhakrishnan, Subbulakshmi Packirisamy and Krishnamoorthy Gunasekaran*

January 29, 2026

DOI : 10.56831/PSMPH-08-272

View PDF

Abstract

Diabetes mellitus is a long-term metabolic disorder of various etiologies hallmarked by chronic hyperglycemia. The prevalence is increasing worldwide, the burden of diabetes in India was approximately 77 million cases in 2019 and is expected to rise to more than 134 million by 2045. Dietary changes continue to be an important part of diabetes prevention and management, helping people achieve their ideal weight, regulate their blood glucose levels, and reduce their risk of complications. Nutrition-based methods, when combined with regular physical activity, can dramatically enhance long-term glycemic control and quality of life.

Keywords: Diet; Essential Fatty Acid; Glycemic Index; Glycemic Load

References

  1. Rajendiran D, S Packirisamy and K Gunasekaran. “A review on role of antioxidants in Diabetes”. Asian Journal of Pharmaceutical and Clinical Research 11.2 (2018): 48-53.
  2. American Diabetes Association. “Standards of medical care in diabetes-2008”. Diabetes Care 31.1 (2008): S12-54.
  3. Shaw JE, Sicree RA and Zimmet PZ. “Global estimates of the prevalence of diabetes for 2010 and 2030”. Diabetes Res Clin Pract 87.1 (2010): 4-14.
  4. Hu FB. “Globalization of diabetes: the role of diet, lifestyle, and genes”. Diabetes Care 34.6 (2011): 1249-57.
  5. Ezzati M and Riboli E. “Behavioral and dietary risk factors for noncommunicable diseases”. N Engl J Med 369.10 (2013): 954-64.
  6. American Diabetes Association., et al. “Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association”. Diabetes Care 1 (2008): S61-78.
  7. Rother KI. “Diabetes treatment--bridging the divide”. N Engl J Med 356.15 (2007): 1499-501.
  8. Gorodezky C., et al. “HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example. Autoimmun Rev 5.3 (2006): 187-194.
  9. American Diabetes Association. “Diagnosis and classification of diabetes mellitus”. Diabetes Care 33.1 (2010): S62-9.
  10. Riserus U, Willett WC and Hu FB. “Dietary fats and prevention of type 2 diabetes”. Prog Lipid Res 48.1 (2009): 44-51.
  11. Williams Textbook of Endocrinology (12th edn). Philadelphia; Elsevier/Saunder: 1371-1435.
  12. Jean M Lawrence., et al. “Trends in the Prevalence of Preexisting Diabetes and Gestational Diabetes Mellitus Among a Racially/Ethnically Diverse Population of Pregnant Women, 1999-2005”. Diabetes Care 31.5 (2008): 899-904.
  13. Magkos F, Hjorth MF and Astrup A. “Diet and exercise in the prevention and treatment of type 2 diabetes mellitus”. Nat Rev Endocrinol 16.10 (2020): 545-555.
  14. Barreira E., et al. “Dietary program and physical activity impact on biochemical markers in patients with type 2 diabetes: A systematic review”. Aten Primaria 50.10 (2018): 590-610.
  15. Slavin J and Carlson J. “Carbohydrates”. Adv Nutr 5.6 (2014): 760-761.
  16. Wheeler ML., et al. “Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, 2010”. Diabetes Care 35.2 (2012): 434-445.
  17. Li Jiao., et al. “Glycemic Index, Carbohydrates, Glycemic Load, and the Risk of Pancreatic Cancer in a Prospective Cohort Study”. Cancer Epidemiol Biomarkers Prev 18.4 (2009): 1144-1151.
  18. Barclay AW., et al. “Glycemic index, glycemic load, and chronic disease risk--a meta-analysis of observational studies”. Am J Clin Nutr 873 (2008): 627-637.
  19. Fiona S Atkinson, Kaye Foster-Powell and Jennie C Brand-Miller. “International Tables of Glycemic Index and Glycemic Load Values: 2008”. Diabetes Care 31.12 (2008): 2281-2283.
  20. Pawlak DB, Kushner JA and Ludwig DS. “Effects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals”. Lancet 364.9436 (2004): 778-85.
  21. Diaz EO, Galgani JE and Aguirre CA. “Glycemic index effects on fuel partitioning in humans”. Obes Rev 7.2 (2006): 219-26.
  22. Sievenpiper JL., et al. “Insulin resistance: concepts, Controversies and the role of nutrition”. Can J Diet Pract Res 63 (2002): 20-32.
  23. Mohan V., et al. “Dietary carbohydrates, glycaemic load, food groups and newly detected type 2 diabetes among urban Asian Indian population in Chennai, India (Chennai Urban Rural Epidemiology Study 59)”. Br J Nutr 102.10 (2009): 1498-506.
  24. Schulze MB., et al. “Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women”. JAMA 292.8 (2004): 927-34.
  25. Dhingra R., et al. “Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community”. Circulation 116.5 (2007): 480-8.
  26. Montonen J., et al. “Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence”. J Nutr 137.6 (2007): 1447-54.   
  27. Palmer JR., et al. “Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women”. Arch Intern Med 168.14 (2008): 1487-92.
  28. Bazzano LA., et al. “Intake of fruit, vegetables, and fruit juices and risk of diabetes in women”. Diabetes Care 31.7 (2008): 1311-7.
  29. Odegaard AO., et al. “Soft drink and juice consumption and risk of physician-diagnosed incident type 2 diabetes: the Singapore Chinese Health Study”. Am J Epidemiol 171.6 (2010): 701-8.
  30. Drouin-Chartier JP., et al. “Changes in Consumption of Sugary Beverages and Artificially Sweetened Beverages and Subsequent Risk of Type 2 Diabetes: Results from Three Large Prospective U.S. Cohorts of Women and Men”. Diabetes Care 42.12 (2019): 2181-2189.
  31. Barclay AW., et al. “Dietary Glycaemic Index Labelling: A Global Perspective”. Nutrients 13.9 (2021): 3244.
  32. Anderson JW, Midgley WR and Wedman B. “Fiber and diabetes”. Diabetes Care 2 (1979): 369-77.
  33. Jenkins AL., et al. Depression of the glycemic index by high levels of beta-glucan fiber in two functional foods tested in type 2 diabetes. Eur J Clin Nutr 56.7 (2002): 622-8.
  34. Marangoni F and Poli A. “The glycemic index of bread and biscuits is markedly reduced by the addition of a proprietary fiber mixture to the ingredients”. Nutr Metab Cardiovasc Dis 18.9 (2008): 602-5.
  35. Schulze MB., et al. “Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis”. Arch Intern Med 167.9 (2007): 956-65.
  36. Slavin JL., et al. “Plausible mechanisms for the protectiveness of whole grains”. Am J Clin Nutr 70.3 (1999): 459S-463S.
  37. Salas-Salvadó J., et al. “Fiber in Obesity-Study Group. Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial”. Br J Nutr. 99.6 (2008): 1380-7.
  38. Wursch P and Pi-Sunyer FX. “The role of viscous soluble fiber in the metabolic control of diabetes. A review with special emphasis on cereals rich in beta-glucan”. Diabetes Care 20.11 (1997): 1774-80.
  39. McRae MP. “Dietary Fiber Intake and Type 2 Diabetes Mellitus: An Umbrella Review of Meta-analyses”. Journal of chiropractic medicine 17.1 (2018): 44-53.
  40. Reynolds AN, Akerman AP and Mann J. “Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses”. PLoS Med 17.3 (2020): e1003053.
  41. Colditz GA., et al. “Weight gain as a risk factor for clinical diabetes mellitus in women”. Ann Intern Med 122.7 (1995): 481-6.
  42. Kinsell LW., et al. Dietary fats and diabetic patient. N.Engl  J Med 261 (1959): 431-434.
  43. Hu FB, van Dam RM and Liu S. “Diet and risk of Type II diabetes: the role of types of fat and carbohydrate”. Diabetologia 44.7 (2001): 805-17.
  44. Storlien LH., et al. “Dietary fats and insulin action”. Diabetologia 39.6 (1996): 621-31.
  45. Van Dam RM., et al. “Dietary fat and meat intake in relation to risk of type 2 diabetes in men”. Diabetes Care 25.3 (2002): 417-24.
  46. Nagy K, Levy J and Grunberger G. “High-fat feeding induce tissue specific alteration in Proportion of activated insulin receptor in rats”. Acta Endocrinologica Copenbagen 122 (1990): 361-8.         
  47. Grundeleger ML and Thenen SW. “Decreased insulin binding, glucose transport, and Glucose metabolism in soleus muscle of rats fed a high-fat diet”. Diabetes 31 (1982): 232-7.
  48. Hedeskov CJ., et al. “Long term fat feeding -induced insulin resistance in normal NMRI mice: post receptor change of liver, muscle and adipose tissue metabolism resembling those of type 2 diabetes”. Acta diabetalogica 29 (1992): 14-9.
  49. Storlein LH., et al. “Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega- 3 fatty acids in muscle phospholipid”. Diabetes 40 (1991): 280-9.
  50. Storlein LH., et al. “Dietary fats and insulin action”. Diabetologia 39 (1996): 621-31.
  51. Thanopoulou AC., et al. “Dietary fat intake as risk factor for the development of diabetes: Multinational, Multicenter study of the Mediterranean Group for the Study of the Diabetes (MGSD)”. Diabetes Care 26 (2003): 302-307.
  52. Glatz JF, Soffers AE and Katan MB. “Fatty acid composition of serum cholesteryl esters and erythrocyte membranes as indicators of linoleic acid intake in man”. Am J Clin Nutr 49 (1989): 269-276.
  53. Kuna A and Achinna P. “Monounsaturated fatty acids for CVD and diabetes: A healthy choice”. Int J Nutr Pharmacol Neurol Dis 3 (2013): 236-48.
  54. Schwing Hackl L, Strasser B and Hoffmann G. “Effects of Monounsaturated Fatty Acids on Glycaemic Control in Patients with Abnormal Glucose Metabolism: A Systematic Review and   Meta-Analysis”. Ann Nutr Metab 58 (2011): 290-296.
  55. Salmeron J., et al. “Dietary fat intake of risk of type 2 diabetes in women”. Amj Clin Nutr 73 (2011): 1019-1026.
  56. Shi Lipeng., et al. “Ascorbic acid supplementation in type 2 diabetes mellitus”. Medicine 99.45 (2020): e23125.
  57. Afkhami-Ardekani M and Shojaoddiny-Ardekani A. “Effect of vitamin C on blood glucose, serum lipids & serum insulin in type 2 diabetes patients”. Indian J Med Res 126.5 (2007): 471-4.
  58. Eriksson J and Kohvakka A. “Magnesium and ascorbic acid supplementation in diabetes mellitus”. Ann Nutr Metab 39.4 (1995): 217-23.
  59. Barbagallo M and Dominguez LJ. “Magnesium and type 2 diabetes”. World J Diabetes 6.10 (2015): 1152-7.
  60. Dong JY., et al. “Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies”. Diabetes Care 34.9 (2011): 2116-22.
  61. Fang X., et al. “Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies”. BMC Med 14.1 (2016): 210.
  62. Bagheri A., et al. “Total, Dietary, and supplemental magnesium intakes and risk of all-cause, cardiovascular, and cancer mortality: a systematic review and dose-response meta-analysis of prospective cohort studies”. Adv Nutr 12 (2021): 1196-210.
  63. Trow LG., et al. “Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes”. Int J Vitam Nutr Res 70.1 (2000): 14-8.
  64. Anderson RA. “Chromium in the prevention and control of diabetes”. Diabetes Metab 26.1 (2000): 22-7.
  65. Omid Asbaghi., et al. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacological Research 161 (2020): 105098.
  66. Talab AT., et al. Effects of Chromium Picolinate Supplementation on Cardiometabolic Biomarkers in Patients with Type 2 Diabetes Mellitus: a Randomized Clinical Trial. Clin Nutr Res 9.2 (2020): 97-106.
  67. Tong X., et al. Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies. Eur J Clin Nutr 65.9 (2011): 1027-31.
  68. Elwood PC., et al. “The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence”. Lipids 45.10 (2010): 925-39.
  69. Dagfinn Aune., et al. “Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies”. The American Journal of Clinical Nutrition 98.4 (2013): 1066-1083.
  70. Nettleton JA., et al. “Saturated Fat Consumption and Risk of Coronary Heart Disease and Ischemic Stroke: A Science Update”. Ann Nutr Metab 70.1 (2017): 26-33.
  71. WHO/FAO. “Diet, Nutrition and the prevention of chronic disease: Report of joint WHO/FAO expert consultation”. World Health Organ Tech Rep Ser 916 (2003): i-viii, 1-149.
  72. Elwood PC, et al. “The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer”. J Am Coll Nutr 27.6 (2008): 723s-34s.
  73. Elwood PC, Pickering JE and Fehily AM. “Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study”. Journal of Epidemiology & Community Health 61 (2007): 695-698.
  74. Choi HK., et al. “Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study”. Arch Int Med 165 (2005): 997-1003.
  75. Liu S., et al. “A prospective study of dairy intake and the risk of type 2 diabetes in women”. Diabetes Care 29 (2006): 1579-1584.
  76. van Dam RM., et al. “Dietary calcium and magnesium, major food sources and risk of type 2 diabetes in US black women”. Diabetes Care 29 (2006):2238-2243.
  77. Liu S., et al. “Intake of dietary saturated fatty acids and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Netherlands cohort: associations by types, sources of fatty acids and substitution by macronutrients”. Eur J Nutr 58 (2019): 1125-1136.
  78. Fumeron F., et al. “Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Study Group. Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a french prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR)”. Diabetes Care 34.4 (2011): 813-7.
  79. Liang N, and Kitts DD. “Antioxidant property of coffee components: assessment of methods that define mechanisms of action”. Molecules (Basel, Switzerland) 19.11 (2014): 19180-19208.
  80. Farah A. “Coffee Constituents”. In Coffee: Emerging Health Effects and Disease Prevention; Chu, Y.F., Ed.; Wiley-Blackwell: Oxford, UK (2012): 21-58.
  81. Svilaas A., et al. “Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasm carotenoids in humans”. J Nutr 134.3 (2004): 562-7.
  82. Pulido R, Hernandez-Garcia M and Saura-Calixto F. “Contribution of beverages to the intake of lipophilic and hydrophilic antioxidants in the Spanish diet”. Eur J Clin Nutr 57 (2003): 1275-1282.
  83. Van Dam RM and HU FB. “Coffee consumption and risk of type 2 diabetes: A systematic review”. JAMA 294 (2005): 97-104.
  84. Muley Arti, Muley Prasad and Shah Monali. “Coffee to Reduce Risk of Type 2 Diabetes? A Systematic Review”. Current Diabetes Reviews 8.3 (2012): 162-8.
  85. Salazar-Martinez E., et al. “Coffee consumption and risk for type 2 diabetes mellitus”. Ann Intern Med 140.1 (2004): 1-8.
  86. Huxley R., et al. “Coffee, decaffeinated coffee and tea consumption about incident type 2 diabetes mellitus; A Systematic review with meta-analysis”. Arch Intern Med 169 (2009): 2053-63.